- Home
- MTNB vs TNON Comparison
MTNB vs TNON Comparison
Compare MTNB & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTNB
- TNON
- Stock Information
- Founded
- MTNB 2013
- TNON 2012
- Country
- MTNB United States
- TNON United States
- Employees
- MTNB N/A
- TNON N/A
- Industry
- MTNB Biotechnology: Pharmaceutical Preparations
- TNON Medical Specialities
- Sector
- MTNB Health Care
- TNON Health Care
- Exchange
- MTNB Nasdaq
- TNON Nasdaq
- Market Cap
- MTNB 9.7M
- TNON 11.5M
- IPO Year
- MTNB N/A
- TNON 2022
- Fundamental
- Price
- MTNB $1.73
- TNON $1.20
- Analyst Decision
- MTNB Hold
- TNON Strong Buy
- Analyst Count
- MTNB 1
- TNON 2
- Target Price
- MTNB N/A
- TNON $5.50
- AVG Volume (30 Days)
- MTNB 118.5K
- TNON 323.7K
- Earning Date
- MTNB 11-12-2025
- TNON 11-12-2025
- Dividend Yield
- MTNB N/A
- TNON N/A
- EPS Growth
- MTNB N/A
- TNON N/A
- EPS
- MTNB N/A
- TNON N/A
- Revenue
- MTNB N/A
- TNON $2,947,000.00
- Revenue This Year
- MTNB N/A
- TNON $43.52
- Revenue Next Year
- MTNB N/A
- TNON $82.14
- P/E Ratio
- MTNB N/A
- TNON N/A
- Revenue Growth
- MTNB N/A
- TNON N/A
- 52 Week Low
- MTNB $0.47
- TNON $0.85
- 52 Week High
- MTNB $4.25
- TNON $9.35
- Technical
- Relative Strength Index (RSI)
- MTNB 52.72
- TNON 46.70
- Support Level
- MTNB $1.59
- TNON $1.13
- Resistance Level
- MTNB $1.88
- TNON $1.26
- Average True Range (ATR)
- MTNB 0.13
- TNON 0.07
- MACD
- MTNB -0.04
- TNON -0.01
- Stochastic Oscillator
- MTNB 28.00
- TNON 39.13
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.